Discrepant results of experimental human mesenchymal stromal cell therapy after myocardial infarction: Are animal models robust enough?

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Haan, Melina C Den ^a   Van Zuylen, Vanessa Leigh ^a   Pluijmert, Niek J ^a   Schutte, Cindy I ^a   Fibbe, Willem E ^a   Schalij, Martin J ^a   Roelofs, Helene ^a   Atsma, Douwe E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE MARROW BIOPSY; CARDIOVASCULAR PARAMETERS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL THERAPY; CELL TRANSPORT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; ENGRAFTMENT; FLOW CYTOMETRY; HEART FUNCTION; HEART INFARCTION; HISTOPATHOLOGY; IMMUNOPHENOTYPING; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LUNG CONGESTION; MALE; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; TREATMENT OUTCOME; TREATMENT RESPONSE; ANIMAL; BIOLOGICAL THERAPY; CYTOLOGY; DISEASE MODEL; HUMAN; MYOCARDIAL INFARCTION; NONOBESE DIABETIC MOUSE; PATHOLOGY; SCID MOUSE;

ANIMALS; CELL- AND TISSUE-BASED THERAPY; DISEASE MODELS, ANIMAL; HUMANS; MAGNETIC RESONANCE IMAGING; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED NOD; MICE, SCID; MYOCARDIAL INFARCTION;

EID: 84963652876     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0152938     Document Type: Article

References (41)

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB et al. (2012) Heart Disease and Stroke Statistics-2012 Update: A Report From the American Heart Association. Circulation 125:e2-e220. CIR.0b013e31823ac046 [pii]; doi: 10.1161/CIR.0b013e31823ac046 PMID: 22179539
2. Nygren JM, Jovinge S, Breitbach M, Sawen P, Roll W, Hescheler J et al. (2004) Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 10:494-501. doi: 10.1038/nm1040 nm1040 [pii]. PMID: 15107841
3. Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, Redmond JM et al. (2002) Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 73:1919-1925. PMID: 12078791
4. Grauss RW, Winter EM, van TJ, Pijnappels DA, Steijn RV, Hogers B et al. (2007) Mesenchymal stem cells from ischemic heart disease patients improve left ventricular function after acute myocardial infarction. Am J Physiol Heart Circ Physiol 293:H2438-H2447. 00365.2007 [pii]; doi: 10.1152/ajpheart. 00365.2007 PMID: 17644573
5. Dixon JA, Gorman RC, Stroud RE, Bouges S, Hirotsugu H, Gorman JH III et al. (2009) Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction. Circulation 120:S220-S229. 120/11-suppl-1/S220 [pii]; doi: 10.1161/CIRCULATIONAHA.108.842302 PMID: 19752372
6. Leor J, Gerecht S, Cohen S, Miller L, Holbova R, Ziskind A et al. (2007) Human embryonic stem cell transplantation to repair the infarcted myocardium. Heart 93:1278-1284. hrt.2006.093161 [pii]; doi: 10.1136/hrt.2006.093161 PMID: 17566061
7. Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, Terzic A (2009) Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 120:408-416. CIRCULATIONAHA.109.865154 [pii]; doi: 10.1161/CIRCULATIONAHA.109.865154 PMID: 19620500
8. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA et al. (1998) Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 4:929-933. PMID: 9701245
9. den Haan MC, Grauss RW, Smits AM, Winter EM, van TJ, Pijnappels DA et al. (2012) Cardiomyogenic differentiation-independent improvement of cardiac function by human cardiomyocyte progenitor cell injection in ischaemic mouse hearts. J Cell Mol Med 16:1508-1521. doi: 10.1111/j.1582-4934.2011. 01468.x PMID: 22003890
10. van RJ, Bax JJ, Beeres SL, Dibbets-Schneider P, Roes SD, Stokkel MP et al. (2009) Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. JAMA 301:1997-2004. 301/19/1997 [pii]; doi: 10.1001/jama.2009.685 PMID: 19454638
11. Krause K, Jaquet K, Schneider C, Haupt S, Lioznov MV, Otte KM et al. (2009) Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction: first-in-man study. Heart 95:1145-1152. hrt.2008.155077 [pii]; doi: 10.1136/hrt.2008.155077 PMID: 19336430
12. van der Bogt KE, Sheikh AY, Schrepfer S, Hoyt G, Cao F, Ransohoff KJ et al. (2008) Comparison of different adult stem cell types for treatment of myocardial ischemia. Circulation 118:S121-S129. 118/14-suppl-1/S121 [pii]; doi: 10.1161/CIRCULATIONAHA.107.759480 PMID: 18824743
13. Williams AR, Hare JM (2011) Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res 109:923-940. 109/8/923 [pii]; doi: 10.1161/CIRCRESAHA.111.243147 PMID: 21960725
14. van Zuylen VL, den Haan MC, Geutskens SB, Roelofs H, Fibbe WE, Schalij MJ et al. (2015) Post-myocardial Infarct Inflammation and the Potential Role of Cell Therapy. Cardiovasc Drugs Ther 29:59-73. doi: 10.1007/s10557-014-6568-z PMID: 25583678
15. Gnecchi M, Zhang Z, Ni A, Dzau VJ (2008) Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103:1204-1219. 103/11/1204 [pii]; doi: 10.1161/CIRCRESAHA.108.176826 PMID: 19028920
16. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S et al. (2004) Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94:678-685. doi: 10.1161/01. RES. 0000118601.37875. AC 01. RES.0000118601.37875. AC [pii]. PMID: 14739163
17. Uemura R, Xu M, Ahmad N, Ashraf M (2006) Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 98:1414-1421. 01. RES.0000225952.61196.39 [pii]; doi: 10.1161/01. RES.0000225952.61196.39 PMID: 16690882
18. Arminan A, Gandia C, Garcia-Verdugo JM, Lledo E, Trigueros C, Ruiz-Sauri A et al. (2010) Mesenchymal stem cells provide better results than hematopoietic precursors for the treatment of myocardial infarction. J Am Coll Cardiol 55:2244-2253. S0735-1097 (10) 00951-4 [pii]; doi: 10.1016/j.jacc.2009. 08.092 PMID: 20466205
19. Grauss RW, van TJ, Steendijk P, Winter EM, Pijnappels DA, Hogers B et al. (2008) Forced myocardin expression enhances the therapeutic effect of human mesenchymal stem cells after transplantation in ischemic mouse hearts. Stem Cells 26:1083-1093. 2007-0523 [pii]; doi: 10.1634/stemcells.2007-0523 PMID: 18203678
20. Duijvestein M, Wildenberg ME, Welling MM, Hennink S, Molendijk I, van Zuylen VL et al. (2011) Pretreatment with interferon-gamma enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis. Stem Cells 29:1549-1558. doi: 10.1002/stem.698 PMID: 21898680
21. Polchert D, Sobinsky J, Douglas G, Kidd M, Moadsiri A, Reina E et al. (2008) IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. Eur J Immunol 38:1745-1755. doi: 10.1002/eji.200738129 PMID: 18493986
22. Croitoru-Lamoury J, Lamoury FM, Caristo M, Suzuki K, Walker D, Takikawa O et al. (2011) Interferongamma regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2, 3 dioxygenase (IDO). PLoS One 6:e14698. doi: 10.1371/journal.pone.0014698 PMID: 21359206
23. Delarosa O, Lombardo E, Beraza A, Mancheno-Corvo P, Ramirez C, Menta R et al. (2009) Requirement of IFN-gamma-mediated indoleamine 2, 3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells. Tissue Eng Part A 15:2795-2806. doi: 10. 1089/ten. TEA.2008.0630 PMID: 19231921
24. Francois M, Galipeau J (2012) New insights on translational development of mesenchymal stromal cells for suppressor therapy. J Cell Physiol 227:3535-3538. doi: 10.1002/jcp. 24081 PMID: 22378308
25. Hemeda H, Jakob M, Ludwig AK, Giebel B, Lang S, Brandau S (2010) Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells. Stem Cells Dev 19:693-706. doi: 10.1089/scd.2009.0365 PMID: 20067407
26. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL et al. (2007) The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 204:3037-3047. jem.20070885 [pii]; doi: 10.1084/jem.20070885 PMID: 18025128
27. McBride C, Gaupp D, Phinney DG (2003) Quantifying levels of transplanted murine and human mesenchymal stem cells in vivo by real-time PCR. Cytotherapy 5:7-18. doi: 10.1080/14653240310000038 MXPHDNV0VX33RX55 [pii]. PMID: 12745583
28. Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P et al. (2009) Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325:612-616. 325/5940/612 [pii]; doi: 10.1126/science.1175202 PMID: 19644120
29. Bollache E, Redheuil A, Clement-Guinaudeau S, Defrance C, Perdrix L, Ladouceur M et al. (2010) Automated left ventricular diastolic function evaluation from phase-contrast cardiovascular magnetic resonance and comparison with Doppler echocardiography. J Cardiovasc Magn Reson 12:63. 1532-429X-12-63 [pii]; doi: 10.1186/1532-429X-12-63 PMID: 21062448
30. Danilouchkine MG, Westenberg JJ, de RA, Reiber JH, Lelieveldt BP (2005) Operator induced variability in cardiovascular MR: left ventricular measurements and their reproducibility. J Cardiovasc Magn Reson 7:447-457. PMID: 15881528
31. Schuleri KH, Feigenbaum GS, Centola M, Weiss ES, Zimmet JM, Turney J et al. (2009) Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. Eur Heart J 30:2722-2732. ehp265 [pii]; doi: 10.1093/eurheartj/ehp265 PMID: 19586959
32. Silva GV, Litovsky S, Assad JA, Sousa AL, Martin BJ, Vela D et al. (2005) Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111:150-156. 01. CIR.0000151812.86142.45 [pii]; doi: 10. 1161/01. CIR.0000151812.86142.45 PMID: 15642764
33. Huang XP, Sun Z, Miyagi Y, McDonald KH, Zhang L, Weisel RD et al. (2010) Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair. Circulation 122:2419-2429. CIRCULATIONAHA.110.955971 [pii]; doi: 10.1161/CIRCULATIONAHA.110.955971 PMID: 21098445
34. Behfar A, Yamada S, Crespo-Diaz R, Nesbitt JJ, Rowe LA, Perez-Terzic C et al. (2010) Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J Am Coll Cardiol 56:721-734. S0735-1097 (10) 02236-9 [pii]; doi: 10.1016/j.jacc. 2010.03.066 PMID: 20723802
35. Hassan F, Meduru S, Taguchi K, Kuppusamy ML, Mostafa M, Kuppusamy P et al. (2012) Carvedilol Enhances Mesenchymal Stem Cell Therapy for Myocardial Infarction via Inhibition of Caspase-3 Expression. J Pharmacol Exp Ther 343:62-71. jpet.112.196915 [pii]; doi: 10.1124/jpet.112.196915 PMID: 22739507
36. Zuo S, Jones WK, Li H, He Z, Pasha Z, Yang Y et al. (2012) Paracrine effect of Wnt11-overexpressing mesenchymal stem cells on ischemic injury. Stem Cells Dev 21:598-608. doi: 10.1089/scd.2011.0071 PMID: 21463175
37. van der Bogt KE, Schrepfer S, Yu J, Sheikh AY, Hoyt G, Govaert JA et al. (2009) Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart. Transplantation 87:642-652. doi: 10.1097/TP.0b013e31819609d9 00007890-200903150-00005 [pii]. PMID: 19295307
38. Loffredo FS, Steinhauser ML, Gannon J, Lee RT (2011) Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell 8:389-398. S1934-5909 (11) 00053-1 [pii]; doi: 10.1016/j.stem.2011.02.002 PMID: 21474103
39. Deuse T, Peter C, Fedak PW, Doyle T, Reichenspurner H, Zimmermann WH et al. (2009) Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cellbased myocardial salvage after acute myocardial infarction. Circulation 120:S247-S254. 120/11-suppl-1/S247 [pii]; doi: 10.1161/CIRCULATIONAHA.108.843680 PMID: 19752375
40. Carr CA, Stuckey DJ, Tatton L, Tyler DJ, Hale SJ, Sweeney D et al. (2008) Bone marrow-derived stromal cells home to and remain in the infarcted rat heart but fail to improve function: an in vivo cine-MRI study. Am J Physiol Heart Circ Physiol 295:H533-H542. 00094.2008 [pii]; doi: 10.1152/ajpheart. 00094.2008 PMID: 18539761
41. Flynn AW, Chen X, O'Connell E, O'Brien T (2012) A comparison of the efficacy of transplantation of bone marrow derived mesenchymal stem cells and unrestricted somatic stem cells on outcome after acute myocardial infarction. Stem Cell Res Ther 3:36. scrt127 [pii]; doi: 10.1186/scrt127 PMID: 22974654